These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1916996)

  • 1. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.
    Dzau VJ; Gibbons GH; Pratt RE
    Hypertension; 1991 Oct; 18(4 Suppl):II100-5. PubMed ID: 1916996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.
    Dzau VJ
    Basic Res Cardiol; 1993; 88 Suppl 1():1-14. PubMed ID: 8395169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular renin-angiotensin system and vascular protection.
    Dzau VJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S1-9. PubMed ID: 7508045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin system and vascular hypertrophy.
    Rosendorff C
    J Am Coll Cardiol; 1996 Oct; 28(4):803-12. PubMed ID: 8837552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
    Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the tissue renin-angiotensin system in vascular remodeling and smooth muscle cell growth.
    Naftilan AJ
    Curr Opin Nephrol Hypertens; 1994 Mar; 3(2):218-27. PubMed ID: 7842273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-mediated growth in aortic smooth muscle and the vascular renin-angiotensin system.
    Kamide K; Hori MT; Zhu JH; Barrett JD; Eggena P; Tuck ML
    Hypertension; 1998 Sep; 32(3):482-7. PubMed ID: 9740614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the renin-angiotensin system in the wall of rat femoral resistance vessels.
    Kvist S; Mulvany MJ; Aalkjaer C
    Eur J Pharmacol; 1991 May; 198(1):77-83. PubMed ID: 1915579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
    Weir MR; Dzau VJ
    Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation of aortic smooth muscle cells and renin-angiotensin system in SHR rats.
    Wang XY; Wu KG; Jin XQ; Wang HJ
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):136-40. PubMed ID: 10374636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists.
    Meyer P; Flammer J; Lüscher TF
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):555-62. PubMed ID: 7890486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
    Sesin J; Tamargo J
    Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endothelium in antithrombotic effect of the renin-angiotensin system blockade.
    Buczko W; Matys T; Kucharewicz I; Chabielska E
    J Physiol Pharmacol; 1999 Dec; 50(4):499-507. PubMed ID: 10639001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and antisense inhibition of a renin-angiotensin system in transgenic cardiomyocytes.
    Cook JL; Bhandaru S; Giardina JF; Claycomb WC; Ré RN
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1471-82. PubMed ID: 7733348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
    Ruschitzka FT; Lüscher TF
    Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells.
    Zhang SL; To C; Chen X; Filep JG; Tang SS; Ingelfinger JR; Carrière S; Chan JS
    Exp Nephrol; 2001; 9(2):109-17. PubMed ID: 11150859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
    Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pathology and treatment of renin-angiotensin system 4. Renin-angiotensin system and insulin resistance.
    Shimamoto K; Miura T
    Intern Med; 2007; 46(16):1303-4. PubMed ID: 17704610
    [No Abstract]   [Full Text] [Related]  

  • 20. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.